The Latest Breaking News from FDA

FDA warns of complications with Hologic's soft tissue medical devices, urging vigilance and reporting.

"We've literally overnight doubled the amount of options we have to manage this disease"

The decades-long failure to curb cigarette addiction reveals a painful legacy of deception towards Black Americans

The pharma market is poised to thrive due to the continuous medicinal advancements to meet the escalating demand for chronic disease treatment, technological advancements, and increased research and development. Given this backdrop, quality pharma stocks Procaps Group S.A. (PROC), Supernus Pharmaceuticals (SUPN), and GSK plc (GSK) could be wise portfolio…

The Food and Drug Administration has warned consumers against using "smart" devices that are marketed to measure blood sugar without piercing the skin.

The DEA is cracking down on manufacturers, hurting patients who genuinely need those drugs.

The biotech industry’s robust growth potential is fueled by scientific advancements, rapid technological adoption, and supportive government initiatives. Thus, you could consider investing in top biotech stocks Exelixis (EXEL), Vertex Pharmaceuticals (VRTX), and Vanda Pharmaceuticals (VNDA) to strengthen your portfolio. Keep reading….

Vertex Pharmaceuticals just released data from its experimental drug to relieve pain, with no risk of addiction and very few side effects. This opioid alternative could give Vertex - already a powerhouse in the cystic fibrosis segment - another blockbuster drug to add to its portfolio.

Trump "likes the idea of a 16-week national abortion ban" but wants to keep it quiet, NY Times reports

Learn about Deep Brain Stimulation (DBS) implant for depression treatment, offering hope and relief for patients like Emily Hollenbeck.

As Tesla stock continues to underperform - now down more than 22% year-to-date - here are 3 mega-cap companies worthy of replacing the beleaguered EV giant in the elite group of mega-cap stocks known as the Magnificent Seven.